好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Peptidyl-Prolyl Isomerase Pin1: A Common Therapeutic Target for Synaptic Dysfunction and Protein Misfolding in Alzheimer's Disease
Aging and Dementia
(-)
008
Authors/Disclosures
Frances E. Chow, MD (UCLA Neuro-Oncology Program) Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Richard M. Tsai, MD (Denali Therapeutics) Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Carol F. Lippa, MD (Thomas Jefferson University) Dr. Lippa has nothing to disclose.
Yuesong Gong No disclosure on file
Edgardo Cristiano, MD (Hospital Italiano De Buenos Aires) Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.